Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Styczynski

Showing results (41-50 of 155) with videos related to

Pageof 16
Sort By:
Journal of Pediatric Hematology/Oncology|June 6, 2023
Infection With Saprochaete Clavata in Children After Hematopoietic Cell TransplantationTomasz Styczynski, Jagoda Sadlok, Monika Richert-Przygonska, et al.
Anticancer Research|April 22, 2011
Prognostic value of persistent peripheral blood and bone marrow lymphoblasts on day 15 of therapy in childhood acute lymphoblastic leukemia as detected by flow cytometryAnna Jaworska-Posadzy, Jan Styczynski, Malgorzata Kubicka, et al.
Bone Marrow Transplantation|November 18, 2022
New trends in the management of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a survey of the Infectious Diseases Working Pary of EBMTSimone Cesaro, Per Ljungman, Gloria Tridello, et al.
Folia Parasitologica|December 12, 2019
Low seroprevalence and low incidence of infection with Toxoplasma gondii (Nicolle et Manceaux, 1908) in pediatric hematopoietic cell transplantation donors and recipients: Polish nationwide studyKrzysztof Czyzewski, Jowita Fraczkiewicz, Malgorzata Salamonowicz, et al.
Haematologica|July 2, 2016
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelinesJan Styczynski, Walter van der Velden, Christopher P Fox, et al.
Bone Marrow Transplantation|March 15, 2018
Protective environment for hematopoietic cell transplant (HSCT) recipients: The Infectious Diseases Working Party EBMT analysis of global recommendations on health-care facilitiesJan Styczynski, Gloria Tridello, J Peter Donnelly, et al.
Anticancer Research|July 5, 2022
Letermovir Prophylaxis for Cytomegalovirus Infection in Children After Hematopoietic Cell TransplantationMonika Richert-Przygonska, Kamila Jaremek, Robert Debski, et al.
Anticancer Research|January 31, 2012
Expression profiles of signal transduction genes in ex vivo drug-resistant pediatric acute lymphoblastic leukemiaJoanna Szczepanek, Monika Pogorzala, Michal Jarzab, et al.
Leukemia & Lymphoma|April 11, 2003
Ex vivo drug resistance profile in childhood acute myelogenous leukemia: no drug is more effective in comparison to acute lymphoblastic leukemiaJan Styczynski, Mariusz Wysocki, Robert Debski, et al.
Journal of Applied Genetics|November 1, 2011
Gene expression signatures and ex vivo drug sensitivity profiles in children with acute lymphoblastic leukemiaJoanna Szczepanek, Michal Jarzab, Malgorzata Oczko-Wojciechowska, et al.
Pageof 16

Showing results (41-50 of 155) with videos related to

Sort By:
Pageof 16
Journal of Pediatric Hematology/Oncology|June 6, 2023
Infection With Saprochaete Clavata in Children After Hematopoietic Cell TransplantationTomasz Styczynski, Jagoda Sadlok, Monika Richert-Przygonska, et al.
Anticancer Research|April 22, 2011
Prognostic value of persistent peripheral blood and bone marrow lymphoblasts on day 15 of therapy in childhood acute lymphoblastic leukemia as detected by flow cytometryAnna Jaworska-Posadzy, Jan Styczynski, Malgorzata Kubicka, et al.
Bone Marrow Transplantation|November 18, 2022
New trends in the management of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a survey of the Infectious Diseases Working Pary of EBMTSimone Cesaro, Per Ljungman, Gloria Tridello, et al.
Folia Parasitologica|December 12, 2019
Low seroprevalence and low incidence of infection with Toxoplasma gondii (Nicolle et Manceaux, 1908) in pediatric hematopoietic cell transplantation donors and recipients: Polish nationwide studyKrzysztof Czyzewski, Jowita Fraczkiewicz, Malgorzata Salamonowicz, et al.
Haematologica|July 2, 2016
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelinesJan Styczynski, Walter van der Velden, Christopher P Fox, et al.
Bone Marrow Transplantation|March 15, 2018
Protective environment for hematopoietic cell transplant (HSCT) recipients: The Infectious Diseases Working Party EBMT analysis of global recommendations on health-care facilitiesJan Styczynski, Gloria Tridello, J Peter Donnelly, et al.
Anticancer Research|July 5, 2022
Letermovir Prophylaxis for Cytomegalovirus Infection in Children After Hematopoietic Cell TransplantationMonika Richert-Przygonska, Kamila Jaremek, Robert Debski, et al.
Anticancer Research|January 31, 2012
Expression profiles of signal transduction genes in ex vivo drug-resistant pediatric acute lymphoblastic leukemiaJoanna Szczepanek, Monika Pogorzala, Michal Jarzab, et al.
Leukemia & Lymphoma|April 11, 2003
Ex vivo drug resistance profile in childhood acute myelogenous leukemia: no drug is more effective in comparison to acute lymphoblastic leukemiaJan Styczynski, Mariusz Wysocki, Robert Debski, et al.
Journal of Applied Genetics|November 1, 2011
Gene expression signatures and ex vivo drug sensitivity profiles in children with acute lymphoblastic leukemiaJoanna Szczepanek, Michal Jarzab, Malgorzata Oczko-Wojciechowska, et al.
Pageof 16